Market Size
The Korea Breast Augmentation Market reached US$ 70.58 million in 2024 and is expected to reach US$ 122.80 million by 2033, growing at a CAGR of 8.1 % during the forecast period 2025-2033.
Breast augmentation is a surgical procedure aimed at enhancing the size, shape, and overall appearance of the breasts. This can be achieved through the placement of implants or fat transfer, depending on the patient's preferences and medical considerations. While often performed for cosmetic purposes, breast augmentation is also used for reconstructive reasons, such as after a mastectomy or to correct congenital abnormalities.
Although the procedure can lead to significant aesthetic improvements, candidates need to have realistic expectations, be aware of potential risks, and seek guidance from a qualified plastic surgeon to determine the most appropriate approach for their individual goals.
Executive Summary
For more details on this report – Request for Sample
Market Dynamics: Drivers & Restraints
Growing Demand for Cosmetic Procedures
The growing demand for cosmetic procedures in South Korea is expected to significantly drive market growth. South Korea has long been at the forefront of the global beauty and cosmetic surgery industry, with a culture that places a strong emphasis on aesthetics.
As more people seek ways to enhance their appearance, breast augmentation is becoming a popular option for those looking to achieve fuller breasts, restore volume lost due to weight changes or pregnancy, or address natural asymmetry. Additionally, the influence of South Korean celebrities and K-pop idols, who often set beauty trends, has made cosmetic enhancements, including breast augmentation, even more desirable.
With an increasing number of people willing to invest in procedures that help them feel more confident and aligned with current beauty standards, the demand for breast augmentation is expected to continue rising, further boosting the market in South Korea.
Additionally, the rising number of breast cancer surgeries in the region also increases the demand for breast augmentation procedures. For instance, according to the National Institute of Health in 2023, around 28,142 individuals were diagnosed with breast cancer in South Korea. This increases the number of breast surgeries and further increases the demand for breast augmentation procedures.
High Costs of Breast Augmentation Surgery
The high cost of breast augmentation surgery is expected to hinder the growth of the South Korean breast augmentation market. While South Korea is known for its advanced medical technology and high-quality cosmetic procedures, the expense of breast augmentation can be a significant barrier for many potential patients. The surgery itself can be costly, and additional expenses such as consultations, post-operative care, and follow-up visits add up.
For a few individuals, these high costs may make the procedure less accessible, especially for individuals of low-income families. For instance, the average cost of breast implants in Korea is between $5,000 (6,600,000 KRW) to $11,000 (14,600,000 KRW). It could be a financial barrier for individuals willing to take up the breast augmentation treatment. As a result, the price factor could deter a portion of the population from opting for breast augmentation, potentially slowing market growth despite strong demand for cosmetic surgery in the country.
Market Segment Analysis
The Korea breast augmentation market is segmented based on augmentation type, application and end-user.
Augmentation Type:
The breast implants segment in the augmentation type is expected to dominate the Korea breast augmentation market share.
Breast implants, particularly silicone and saline-based, remain the most common choice for women seeking breast enhancement because of their ability to provide a natural look and feel. This preference is reinforced by the consistent launch of new, advanced implant technologies, such as the introduction of "gummy bear" implants, which offer a more natural shape and improved durability.
Additionally, the number of individuals opting for breast implants in South Korea continues to rise, driven by the country’s culture of beauty and aesthetic standards. South Korea is a global leader in cosmetic surgery, and breast augmentation is among the most popular procedures, with implants being the preferred method for many patients.
The rising partnerships among global companies are expected to expand the country’s market growth. For instance, in July 2022, GC Aesthetics a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets announced a new strategic distributor partnership with UMECO GROUP, a leading Korean medical device distributor, focused on aesthetic, beauty, and medical markets.
This exclusive partnership ensures women and Plastic Surgeons in Korea, to have access to the broad, reliable, long-term proven safe GC Aesthetics product range, for breast enhancement surgery. The continued popularity of breast implants can also be attributed to the influence of celebrities and the entertainment industry, which sets beauty trends and encourages more people to seek implants for enhanced breast size and shape.
As more clinics offer innovative implant options and medical tourism increases, more individuals are turning to breast implants for their reliable results, making this segment the dominant force in the Korean breast augmentation market.
Major Players
The major players in the Korean breast augmentation market include Establishment Labs Inc., Hans Biomed Corp, GC Aesthetics, and MENTOR Worldwide LLC among others.
Market Scope
| Metrics | Details | |
| CAGR | 8.1% | |
| Market Size Available for Years | 2022-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Mn) | |
| Segments Covered | Augmentation Type | Breast Implants, Fat Transfer Augmentation |
| Application | Reconstructive Surgery, Cosmetic Surgery | |
| End-User | Hospitals, Cosmetology Clinics | |
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The Korea breast augmentation market report delivers a detailed analysis with 21 key tables, more than 18 visually impactful figures and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
